IL4 and B-cell chronic lymphocytic leukemia: Treatment of CLL cells with selinexor blunted protective effects from anti-apoptotic, pro-survival signals from TNF, IL-6, interleukin-4 (IL-4), BAFF, and CD40L in vitro and also blunted anti-apoptotic effects of marrow-derived fibroblast co-culture model.